Target Audience: Based on the attendance history we anticipate 175-200 participants. These attendees will be primarily physicians (65%) specializing in surgery, oncology, molecular imaging, plastic surgery, radiation oncology, thoracic medicine with the remainder a mixture of predominately PhD/scientists from both academia and biotechnology as well as a smaller groups of attendees who are in training, regulatory or from industry. There will be plenty of opportunities for participants to network with each other as well as the faculty and industry representatives.
Most of the Live Presentations will be included on the Symposium Website and made available to attendees following the Congress as well as to researchers and clinicians around the world for years to come.
A separate ballroom has been reserved for the posters, commercial exhibits and industry sponsored breakfast and lunch symposia on the most significant cancers or oncology topics related to late breaking results from clinical trials in cancer therapy.
We are confident that this CME accredited activity in San Francisco will make a significant impact by expanding the understanding and practices of oncologists involved in the management of cancer and bringing the clinical relevance of cancer metastasis to the basic scientists.
Please click the links below for more information about attending the Symposium: